Is the ‘Ozempic era’ an opportunity for no-and-low?
Why does this matter?
A major consumer health trend (GLP-1 drugs) is driving 36% forecast growth in no/low-alcohol beverages by 2029, creating significant product innovation opportunities and requiring strategic repositioning for beverage startups.
Highlights
With growing research to suggest GLP-1 drugs reduce the desire to drink alcohol, Eloise Feilden